Chelmicka Schorr E - Search Results

1

Narcolepsy with cataplexy as presenting symptom of occult neuroblastoma.

Sinsioco C, Silver K, Forrest KM, Gray J, Nechay A, Sheldon S, Chelmicka Schorr E. Sinsioco C, et al. Among authors: chelmicka schorr e. Pediatr Neurol. 2013 Jul;49(1):64-7. doi: 10.1016/j.pediatrneurol.2012.12.038. Pediatr Neurol. 2013. PMID: 23827430

2

A novel FKRP mutation in congenital muscular dystrophy disrupts the dystrophin glycoprotein complex.

MacLeod H, Pytel P, Wollmann R, Chelmicka-Schorr E, Silver K, Anderson RB, Waggoner D, McNally EM. MacLeod H, et al. Among authors: chelmicka schorr e. Neuromuscul Disord. 2007 Apr;17(4):285-9. doi: 10.1016/j.nmd.2007.01.005. Epub 2007 Mar 1. Neuromuscul Disord. 2007. PMID: 17336067

3

A variant of Fukuyama congenital muscular dystrophy in a non-Japanese child.

Kohrman MH, Picchietti DL, Wollmann R, Chelmicka-Schorr EE. Kohrman MH, et al. Among authors: chelmicka schorr ee. Pediatr Neurol. 1986 Sep-Oct;2(5):290-3. doi: 10.1016/0887-8994(86)90023-8. Pediatr Neurol. 1986. PMID: 3508701

4

Sympathetic nervous system derived trophic factor augments growth of human neuroblastoma in vitro.

Chelmicka-Schorr E, Checinski ME. Chelmicka-Schorr E, et al. Eur J Cancer Clin Oncol. 1989 Feb;25(2):393-4. doi: 10.1016/0277-5379(89)90037-0. Eur J Cancer Clin Oncol. 1989. PMID: 2702993 No abstract available.

5

PC12 pheochromocytoma and sympathetic nervous system derived trophic factors augment growth of neuroblastoma.

Chelmicka-Schorr E, Checinski ME, Arnason BG. Chelmicka-Schorr E, et al. Eur J Cancer Clin Oncol. 1989 Jul;25(7):1057-9. doi: 10.1016/0277-5379(89)90388-x. Eur J Cancer Clin Oncol. 1989. PMID: 2759161

6

Nervous system-immune system interactions and their role in multiple sclerosis.

Chelmicka-Schorr E, Arnason BG. Chelmicka-Schorr E, et al. Ann Neurol. 1994;36 Suppl:S29-32. doi: 10.1002/ana.410360710. Ann Neurol. 1994. PMID: 8017886 No abstract available.

7

Muscle acid protease activity in amyotrophic lateral sclerosis: correlation with clinical and pathologic features.

Antel JP, Chelmicka-Schorr E, Sportiello M, Stefansson K, Wollmann RL, Arnason BG. Antel JP, et al. Among authors: chelmicka schorr e. Neurology. 1982 Aug;32(8):901-3. doi: 10.1212/wnl.32.8.901. Neurology. 1982. PMID: 7048130

8

Sympathectomy augments adoptively transferred experimental allergic encephalomyelitis.

Chelmicka-Schorr E, Kwasniewski MN, Wollmann RL. Chelmicka-Schorr E, et al. J Neuroimmunol. 1992 Mar;37(1-2):99-103. doi: 10.1016/0165-5728(92)90160-m. J Neuroimmunol. 1992. PMID: 1548379

9

The beta 2-adrenergic agonist terbutaline suppresses acute passive transfer experimental autoimmune myasthenia gravis (EAMG).

Chelmicka-Schorr E, Wollmann RL, Kwasniewski MN, Kim DH, Dupont BL. Chelmicka-Schorr E, et al. Int J Immunopharmacol. 1993 Jan;15(1):19-24. doi: 10.1016/0192-0561(93)90027-v. Int J Immunopharmacol. 1993. PMID: 8432621

10

The beta 2-adrenergic agonist terbutaline suppresses experimental allergic neuritis in Lewis rats.

Kim DH, Muthyala S, Soliven B, Wiegmann K, Wollmann R, Chelmicka-Schorr E. Kim DH, et al. Among authors: chelmicka schorr e. J Neuroimmunol. 1994 May;51(2):177-83. doi: 10.1016/0165-5728(94)90079-5. J Neuroimmunol. 1994. PMID: 8182115

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38 results

Search Page

Filters